Company Overview

GE HealthCare Technologies Inc. (GEHC) is a global medical technology, diagnostics, and digital solutions company operating within the healthcare equipment and services industry. The company develops, manufactures, and services technologies used across medical imaging, ultrasound, patient monitoring, diagnostics, and digital health. Its primary revenue drivers are capital equipment sales, recurring service contracts, consumables, and software-enabled clinical solutions sold to hospitals, health systems, diagnostic centers, and life sciences customers.

GEHC is positioned as a large-scale, diversified healthcare technology provider with a strong installed base and long-term customer relationships, which create recurring service and upgrade revenue. The company traces its origins to General Electric’s healthcare business, which was established over a century ago and expanded through decades of internal development and acquisitions. GEHC became an independent public company in January 2023 following its spin-off from General Electric, allowing it to pursue focused investment and capital allocation aligned solely with healthcare markets.

Business Operations

GEHC operates through four primary business segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment includes technologies such as MRI, CT, X-ray, PET, and molecular imaging systems. Ultrasound provides diagnostic imaging solutions across radiology, cardiology, women’s health, and point-of-care applications. Patient Care Solutions focuses on monitoring, anesthesia, and clinical care systems used in acute and critical care environments. Pharmaceutical Diagnostics develops and supplies contrast media and radiopharmaceuticals used in diagnostic imaging procedures.

Revenue is generated through a mix of equipment sales, long-term service agreements, consumables, and digital software offerings. GEHC maintains domestic operations in the United States and extensive international operations, supported by manufacturing facilities, R&D centers, and service organizations. The company controls proprietary imaging platforms, AI-enabled clinical software, and a large global service infrastructure, and it maintains commercial and technology partnerships with healthcare providers and technology firms to support product development and distribution.

Strategic Position & Investments

GEHC’s strategy emphasizes innovation in precision care, artificial intelligence, and workflow automation to improve clinical outcomes and operational efficiency for healthcare providers. Growth initiatives include expanding AI-enabled imaging and diagnostics, increasing penetration in emerging markets, and growing recurring revenue from services and digital solutions. The company has publicly identified digital health, data analytics, and molecular diagnostics as priority investment areas.

Since becoming independent, GEHC has pursued targeted acquisitions to enhance its technology portfolio, including MIM Software, Caption Health, and IMACTIS, which strengthen its capabilities in advanced visualization, AI-guided imaging, and interventional guidance. The company also maintains strategic collaborations with technology partners to accelerate AI development and cloud-enabled healthcare solutions, while continuing internal investment in R&D to support long-term product innovation.

Geographic Footprint

GEHC is headquartered in Chicago, United States, and operates on a global scale across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The company serves customers in more than 160 countries, supported by a broad network of manufacturing sites, research centers, and service teams.

International markets represent a significant portion of revenue, with strong positions in developed healthcare markets and expanding presence in emerging economies. GEHC’s global footprint enables localized product development, regulatory compliance, and service delivery, while also providing exposure to long-term growth trends in global healthcare demand and aging populations.

Leadership & Governance

GEHC is led by an executive team with experience in healthcare technology, global operations, and capital markets. The leadership team emphasizes operational discipline, customer-centric innovation, and long-term value creation following the company’s transition to an independent public entity.

Key executives include:

• Peter Arduini – President and Chief Executive Officer
• Helmi Talasila – Chief Financial Officer
• Elizabeth L. Dickey – President and Chief Executive Officer, Imaging
• Catherine Estrampes – Chief Commercial Officer

The company operates under a board-governed structure consistent with U.S. public company standards, with oversight of strategy, risk management, and executive compensation aligned to performance and shareholder interests.